Search studies

4 studies found

204869 Phase 2a/b in Ulcerative Colitis
ELU-4-907C53-1

204869 Phase 2a/b in Ulcerative Colitis

AMCUC study
ELU-4-54A576-1

AMCUC study

LUCENT-1 (NCT 03518086)
ELU-4-58F581-1

An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

Pfizer
ELU-4-B16B4B-1

204869 Phase 2a/b in Ulcerative Colitis